Betty Y.S. Kim

Has grant

Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Betty Y.S. Kim is a faculty member at The University of Texas MD Anderson Cancer Center in the United States. Her research focuses on innovative approaches in immuno-oncology, including the use of nanotechnology and multi-omics strategies to enhance cancer treatment. She has authored several recent articles exploring tumor antigens, immune activation, and the development of bispecific antibodies for improved therapy outcomes.

Recent Grants

Grant: Close

Targeted Breast Cancer Immunotherapy

Open Date: 2019-09-01

Close Date: 2022-09-01

Grant: Close

Therapeutic modulation of the phagocytosis axis as a novel glioblastoma immunotherapy

Open Date: 2018-03-01

Close Date: 2022-12-31

Grant: Close

Therapeutic modulation of the phagocytosis axis as a novel glioblastoma immunotherapy

Open Date: 2018-03-01

Close Date: 2022-12-31

Grant: Close

ICS INMHA Brain Star Award

Open Date: 2009-01-01

Close Date: 2009-03-31

Grant: Close

ICS INMHA Brain Star Award

Open Date: 2009-01-01

Close Date: 2009-03-31

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Betty Y.S. Kim

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (18)

Nanotechnology for immuno-oncology

Uncovering the hidden landscape of tumour antigens

Multi-omics approaches to decipher the interactions of nanoparticles and biological systems

Learning what keeps nanomedicines in tumours

Striking the Balance with a PD-L1×4–1BB Bispecific Antibody

Response of treatment-naive brain metastases to stereotactic radiosurgery

Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity

Engineering nanomaterial physical characteristics for cancer immunotherapy

Waking immune-resistant tumors with neddylation

Leptomeningeal Immunoglobulin G4–Related Disease: A Case Report

Advanced Immunotherapy Approaches for Glioblastoma

Considerations for designing preclinical cancer immune nanomedicine studies

Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy

Self-Assembled pH-Sensitive Polymeric Nanoparticles for the Inflammation-Targeted Delivery of Cu/Zn-Superoxide Dismutase

Spatiotemporal Immunomodulation Using Biomimetic Scaffold Promotes Endochondral Ossification-Mediated Bone Healing

Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function

Nanotechnology platforms for cancer immunotherapy

Assessment of Trends in Second Primary Cancers in Patients with Metastatic Melanoma from 2005 to 2016

Collaborators (7)

Benjamin Schrank

Cesar Simbaqueba Clavijo

David Rubio

Wen Jiang

Jeffrey Weinberg

Jacques Lux

Ashley Aaroe

Make your next move.